Results 201 to 210 of about 45,688 (235)

Identification of small molecule inhibitors targeting FGFR through molecular docking-based screening. [PDF]

Front Oncol
Hou W, Liu K, Wang P, Zheng K, Kong Q, Wang X, Zhao Q, Cheng L.   +7 more
europepmc   +1 more source

The FGF-FGFR axis as an immune-metabolic rheostat in gastrointestinal inflammation and cancer. [PDF]

Front Immunol
Saad KSS, Zhou C, Lu G, Wei G, Cha H, Alwabri E, Zhang Z, Sun Z, Liao Y.   +8 more
europepmc   +1 more source

<i>FGFR2</i> fusions as novel oncogenic drivers in gastrointestinal stromal tumors: Two case reports and review of literature. [PDF]

World J Gastrointest Oncol
Hong YY, Shou CH, Yang WL, Wang XD, Zhang Q, Liu XS, Yu JR.   +6 more
europepmc   +1 more source

FGF receptor 2 signaling in granulosa cells is required for normal female fertility in mice. [PDF]

Reproduction
Kanke T, Ichikawa A, Akimoto Y, Matsunaga S, Fujii W, Endo T, Naito K, Sugiura K.   +7 more
europepmc   +1 more source

Translating Gastric Cancer Genomics into Targeted Therapy: Mechanistic Insights from Animal Models and Patient-Derived Systems. [PDF]

Cells
Shyu RY, Wang LK, Tsai FM.
europepmc   +1 more source

A smart nanocomposite bioactive ink for controlled siRNA delivery in calvarial mesenchymal stromal cells as a minimally invasive treatment for craniosynostosis. [PDF]

Regen Biomater
Salvati M, Tiberio F, Giacon N, Augello A, Tamburrini G, Di Pietro L, Vita A, Tosi DD, Perini G, Canini G, Sibilia D, Palmieri V, Papi M, Parolini O, Massimi L, Arcovito A, Lattanzi W.   +16 more
europepmc   +1 more source

From a Polymorphous Low-Grade Neuroepithelial Tumor to a Glioblastoma in an Adult Patient with FGFR3-TACC3 Fusion: A Case Report and Literature Review of the Molecular Profile. [PDF]

Curr Oncol
Gurrieri L, Riva N, Tomassini A, Ghigi G, Naccarato M, Cenni P, Bartolini D, Cavatorta C, Tosatto L, Dall'Agata M, Ridolfi L.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Digestive Diseases and Sciences, 2021
FGFR2 genomic alterations are observed in 10-20% of cholangiocarcinoma (CCA). Although FGFR2 fusions are an important actionable target, FGFR2 protein expression has not been thoroughly characterized.To evaluate FGFR2 protein expression in cholangiocarcinoma harboring FGFR2 genomic alterations.FGFR2 protein expression was evaluated in 99 CCA cases with
Pedro Luiz Serrano Uson Junior, Thomas T. DeLeon, James M. Bogenberger, Rish K. Pai, Heidi E. Kosiorek, Jun Yin, Daniel H. Ahn, Mohammad Bassam Sonbol, Tanios Bekaii-Saab, Aaron S. Mansfield, Kenneth Buetow, Gregory J. Gores, Rory Smoot, George Vasmatzis, Benjamin R. Kipp, Amit Mahipal, Alexander T. Baker, Hani Babiker, Oumar Barro, Chelsae Dumbauld, Yumei Zhou, Faaiq N. Aslam, Michael Barrett, Bertram Jacobs, Nathalie Meurice, Mansi Arora, Joachim Petit, Natalie Elliott, Bolni Nagalo, Marcela A. Salomao, Mitesh J. Borad   +30 more
openaire   +2 more sources

A novel mutation in FGFR2

American Journal of Medical Genetics Part A, 2014
Craniosynostosis is a congenital anomaly that can occur as an isolated condition or as part of a syndrome. Although several genes are known to cause syndromic craniosynostosis, only 24% can be attributed to known genes. Therefore, it is likely that more mutations and other genes are involved.
Goos, Jacqueline, van den Ouweland, Ans, Swagemakers, Sigrid, Verkerk, Annemieke, Hoogeboom, Jeannette, van Veelen - Vincent, M.L.C., Mathijssen, Irene, van der Spek, Peter   +7 more
openaire   +3 more sources